Clinical Trial

Medium Chain Triglycerides (MCT) Intake and Age

Study Description

Acute Medium Chain Triglycerides (MCT) Intake in Young and Older Participants

Compare plasma metabolites following different conditions paired with a dietary MCT beverage over an 8-hour metabolic day protocol in young and older participants.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Dietary Supplement - No MCT intake with breakfast, no lunch

Water given with a regular standardize breakfast and water given at noon without lunch.

Dietary Supplement - No MCT intake with lunch, no breakfast

Water given in the beginning of the metabolic study day without breakfast and water given at noon with a regular standardize lunch.

Dietary Supplement - 10g of Betaquik

BQ10 given with a regular standardize breakfast and BQ10 given at noon without lunch.

Dietary Supplement - 10g of Betaquik with low-carbs breakfast

BQ10 given with a low-carbs standardize breakfast and BQ10 given at noon without lunch.

Dietary Supplement - 20g of Betaquik

BQ20 given with a regular standardize breakfast and BQ20 given at noon without lunch.

Dietary Supplement - 10g of Betaquik with lunch, no breakfast

BQ10 given in the beginning of the metabolic study day without breakfast and BQ10 given at noon with a regular standardize lunch.

Additional Information

Official Study Title

Optimisation of Acute Medium Chain Triglycerides Intake Characteristics on Different Plasma Metabolites in Young and Older Participants

Clinical Trial ID

NCT03830268

ParticipAid ID

bo2XNa